Literature DB >> 1701206

Substance P stimulates neovascularization in vivo and proliferation of cultured endothelial cells.

M Ziche1, L Morbidelli, M Pacini, P Geppetti, G Alessandri, C A Maggi.   

Abstract

We have investigated the possible effect of substance P (SP), a main mediator of neurogenic inflammation, on the growth of capillary vessels in vivo, and on the proliferation of cultured endothelial cells in vitro. Slow release preparations of SP were implanted into the avascular cornea of New Zealand White rabbits and vessel growth was monitored daily through a slit lamp stereomicroscope. SP (1-5 micrograms/pellet) induced a marked neovascularization. A selective NK-1 receptor agonist [beta-Ala4, Sar9, Met(O2)11]-SP(4-11) also induced neovascularization. The addition of SP to serum-free cultured endothelial cells, isolated from bovine adrenals (BACE) and from human umbilical cord veins (HUVE), increased proliferation of both cell lines in a concentration-dependent manner with maximal activity at 10(-8) M (BACE) and 10(-10) M (HUVE). The selective NK-1 receptor agonist induced a similar proliferative action on both cell lines, while the selective NK-2 receptor agonist [beta-Ala8]-NKA(4-10) and the selective NK-3 receptor agonist [MePhe7]-NKB had no significant effect. Two different SP antagonists [D-Pro2, D-Trp7,9]-SP and [D-Pro4, D-Trp7,9,Phe11]-SP (4-11) blocked the response to SP. These findings indicate that SP can directly stimulate the process of neovascularization, probably through induction of endothelial cell proliferation. This hitherto unraveled activity of SP could play a key role in the trophic action produced by activation of the efferent function of peripheral endings of primary sensory neurons.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1701206     DOI: 10.1016/0026-2862(90)90024-l

Source DB:  PubMed          Journal:  Microvasc Res        ISSN: 0026-2862            Impact factor:   3.514


  63 in total

1.  Differentiation state determines neural effects on microvascular endothelial cells.

Authors:  Lara A Muffley; Shin-Chen Pan; Andria N Smith; Maricar Ga; Anne M Hocking; Nicole S Gibran
Journal:  Exp Cell Res       Date:  2012-06-07       Impact factor: 3.905

2.  Substance P affects growth factors in Pseudomonas aeruginosa-infected mouse cornea.

Authors:  Megan E B Foldenauer; Sharon A McClellan; Ronald P Barrett; Yunfan Zhang; Linda D Hazlett
Journal:  Cornea       Date:  2012-10       Impact factor: 2.651

3.  Substance P promotes wound healing in diabetes by modulating inflammation and macrophage phenotype.

Authors:  Ermelindo C Leal; Eugénia Carvalho; Ana Tellechea; Antonios Kafanas; Francesco Tecilazich; Cathal Kearney; Sarada Kuchibhotla; Michael E Auster; Efi Kokkotou; David J Mooney; Frank W LoGerfo; Leena Pradhan-Nabzdyk; Aristidis Veves
Journal:  Am J Pathol       Date:  2015-04-11       Impact factor: 4.307

4.  Substance P immunoreactive fibers of synovial tissue in patients with anterior cruciate ligament injury.

Authors:  Bo Zhang; Takeshi Muneta; Kazuyoshi Yagishita; Ichiro Sekiya
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2006-01-04       Impact factor: 4.342

Review 5.  Dermatological and immunological conditions due to nerve lesions.

Authors:  D Bove; A Lupoli; S Caccavale; V Piccolo; E Ruocco
Journal:  Funct Neurol       Date:  2013 Apr-May

6.  The proliferative and antiapoptotic effects of substance P are facilitated by formation of a beta -arrestin-dependent scaffolding complex.

Authors:  K A DeFea; Z D Vaughn; E M O'Bryan; D Nishijima; O Déry; N W Bunnett
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

7.  Substance P enhances wound closure in nitric oxide synthase knockout mice.

Authors:  Pornprom Muangman; Richard N Tamura; Lara A Muffley; F Frank Isik; Jeffrey R Scott; Chengyu Xie; Gary Kegel; Stephen R Sullivan; Zhi Liang; Nicole S Gibran
Journal:  J Surg Res       Date:  2008-05-16       Impact factor: 2.192

8.  The NK-1 receptor antagonist aprepitant as a broad spectrum antitumor drug.

Authors:  Miguel Muñoz; Marisa Rosso
Journal:  Invest New Drugs       Date:  2009-01-17       Impact factor: 3.850

Review 9.  In Vitro Innovation of Tendon Tissue Engineering Strategies.

Authors:  Maria Rita Citeroni; Maria Camilla Ciardulli; Valentina Russo; Giovanna Della Porta; Annunziata Mauro; Mohammad El Khatib; Miriam Di Mattia; Devis Galesso; Carlo Barbera; Nicholas R Forsyth; Nicola Maffulli; Barbara Barboni
Journal:  Int J Mol Sci       Date:  2020-09-14       Impact factor: 5.923

10.  [Leu8]des-Arg9-bradykinin inhibits the angiogenic effect of bradykinin and interleukin-1 in rats.

Authors:  D E Hu; T P Fan
Journal:  Br J Pharmacol       Date:  1993-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.